Introduction
β-catenin and γ-catenin but not E-cadherin. The presence of two different complexes within the same cell results in specific binding. One complex consists of Ecadherin, α-and β-catenin, whereas the other contains E-cadherins and α-and γ-catenins [10] .
Reduction in E-cadherin expression or its loss has been described in carcinomas affecting many organs, including the large intestine [11] , the stomach [12] , the esophagus [13] , the lungs [14] , or the prostate [15] .
β-catenin plays two important functions. It is involved in cell adhesion, binding E-cadherin to the actin cytoskeleton via α-catenin [16] . β-catenin is also a key element in cell signaling via the WNT/wingless pathway. It is usually "confiscated" in the process of adhesion with E-cadherin. Free β-catenin undergoes proteasomal degradation via phosphorylation by glycogen synthetase kinase 3β (GSK-3β). When the activity of GSK-3β is blocked by activation of the WNT pathway, β-catenin accumulates within the cytoplasm at high levels [17] . Mutations in β-catenin gene are uncommon in lung, breast or kidney carcinoma cell lines. However, it has been demonstrated that deletion in a part of the β-catenin gene in a signet ring cell carcinoma cell line is responsible for dysfunctional E-cadherin expression [18] .
The α-catenin is directly bound to the cytoplasmic domain of the cadherin. This binding is the first step in a complex connection between cadherin and the actin filament. Mutation in α-catenin gene can be one of the mechanisms responsible for the loss of proper cell-cell adhesion [2] .
γ-catenin shows strong expression in normal tissues, but not in tumors. The loss of γ-catenin expression can be due to the presence of the two cadherincatenin complexes within a cell. Moreover, γ-catenin exhibits high homology with β-catenin, which suggests that these proteins may be functionally interchangeable [2] .
The E-cadherin-catenin complex plays an important role in the process of cell adhesion and partly in cell signal transduction. Its dysfunction is associated with a reduction or loss of cell and tissue differentiation and with higher invasiveness and metastasis potential. In the present study, we made an attempt to investigate the role of the E-cadherin-catenin complex in the process of metastasizing advanced gastric carcinomas.
Material and methods
Collection of samples. The study was conducted on a group of 91 patients (29 women, 62 men) with advanced gastric carcinoma treated surgically in II Department of General Surgery and Gastroenterology, Medical University of Bia³ystok in the years 1998-2003.
Immunohistochemistry. Formalin-fixed, paraffin-embedded tissue specimens were cut on a microtome into 5 μm thick sections, which were then deparaffinized in xylenes and hydrated in alcohol series of a decreasing concentration. In order to visualize antigen, the sections were heated in a microwave for 15 min in citrate buffer (pH 6.0) and incubated with 0.5% hydrogen peroxide. To block the endogenous activity of peroxidase, incubation was performed in blocking serum (Novostain Super ABC Universal Kit) for 30 min. Next, the samples were incubated with monoclonal antibodies: E-cadherin (NCL-E-Cad, Novocastra Laboratories Ltd; dilution 1:50) -for 60 min, β-catenin (NCL-B-CAT, Novocastra Laboratories Ltd) -for 60 min; dilution 1:100, α-cathenin (α-E-caten, Santa Cruz Biotechnology) -overnight at 4°C, dilution 1:300 and γ-catenin (γ-catenin, Santa Cruz Biotechnology) -overnight at 4oC, dilution 1:100. Reaction was performed in ABC technique using Novostain Super ABC Universal Kit (NCL-ABCm, Novocastra Laboratories Ltd.). Color reaction for peroxidase was done with DAB chromogen (DAKO S3000, DAKO, Poland).
Evaluation of samples. Protein expression was assessed using a semi-quantitative method and defined as follows:
• High expression -when more than 30% cancer cells were Ecadherin-catenin positive • Low expression -when there was no reaction or less than 30% of cells were E-cadherin-catenin positive.
At least 500 cancer cells in each tissue specimen were microscopically found to be E-cadherin-catenin positive (400×).
Statistical analysis. Statistical analysis was carried out based on the χ 2 test and Fisher's exact test. The value of p<0.05 was considered statistically significant. The correlation between the expressions of the proteins examined and postoperative survival was determined by Cox analysis.
Results
Statistical analysis showed no relationship between the expression of the E-cadherin-catenin complex in the main mass of tumor and gender. What is more, no relationship was also observed between E-cadherin, α-, γ-catenin and tumor location or invasion depth. Moreover, there was no correlation found between E-cadherin and β-, α-catenin expression in tumor and histological differentiation grade. Also the expression of α-and γ-catenin was not correlated with lymph node involvement ( Table 1, 3) . However, a statistically significant correlation was revealed of β-catenin expression with tumor location (p=0.023) and depth of stomach wall penetration (p=0.027) ( Table 1 ). In advanced gastric cancer the expressions of E-cadherin and β-catenin were strongly correlated with metastases to lymph nodes (p<0.05) ( Table 2 ). Tumor γ-catenin expression was found to correlate with histological differentiation grade (p=0.02) and with Lauren's classification (p=0.002) ( Table 1) . Moreover, there was a borderline association between β-catenin expression in the affected lymph node and tumor location (p=0.07) ( Table 2) . No correlation was revealed between the expressions of E-cadherin, α-and γ-catenin in the affected lymph node and the parameters studied ( Table 2, Table 1 . Correlation between the expression of E-cadherin, β-catenin proteins and clinicopathological parameters in gastric cancer.
NS -non statistical significence
NS -non statistical significence Table 2 . Correlation between the expression of E-cadherin, β-catenin proteins and clinicopatholgical parameters in lymph node metastasis. Table 3 . Association between the expression of α-cadherin, γ-catenin and clinicopathological parameters in main mass of gastric carcinoma.
NS -non statistical significence NS -non statistical significence Table 4 . Association between the expression of α-cadherin, γ-catenin and clinicopathological parameters in lymph node metastasis. compared to 62 months observed in those without the expression. Increased mortality in patients with strong immunohistochemical reaction in tumor was noted between 5-32 months after surgery. No correlation was observed between positive staining for α-, β-and γ-catenins in the main mass of tumor and survival rate (Fig. 2, 3, 4) . Patients with tumor α-and β-catenin expression had much longer survival (89 months) as compared to those with the expression loss (61 months). An opposite correlation was recorded in the case of γ-catenin expression: patients with positive tumor γ-catenin expression were found to survive for about 60 months after surgery as compared to those without (84 months).
Discussion
E-cadherin mediates adhesive interactions between epithelial cells and exerts an effect on the organization of the actin cytoskeleton through binding to catenins. E-cadherin has been defined as a suppressor gene of invasion that is frequently inhibited or undergoes mutation in invasive tumors [19] . Dysfunction of CDH1 gene (E-cadherin-coding gene) together with mutation have been found in diffuse-type gastric carcinoma [20] . Mutation in CDH1 is a genetic defect found in approximately 1/3 of familial gastric cancers such as hereditary diffuse gastric cancers (HDGC) (Lu) . Deletions of exon 8 or 9, being the Ca 2+ binding sites in the intracellular domain, were most common [21] . In our study, positive staining for E-cadherin was much more frequent in intestinal-type carcinomas according to Lauren's classification than in diffuse type. No statistically significant correlation was also observed between E-cadherin expression and patients' gender or histological differentiation grade. This is consistent with the results reported by Chen et al. [22] , who found no correlation between E-cadherin and can- cer stage, vascular invasion, lymph node involvement or the presence of distant metastases. However, loss of E-cadherin expression was much more frequent in carcinomas that metastasize to distant organs than in those which do not [22] . On the other hand, Scartozzi et al. [23] observed "abnormal" E-cadherin expression more frequently in diffuse-type gastric cancer than in intestinal type according to Lauren's classification. Karayiannakis et al. [24] found a significant correlation of "abnormal" E-cadherin expression with tumor differentiation grade, location and lymph node involvement. Loss of normal E-cadherin expression can serve as a differentiation marker in gastric carcinoma [24] . Moreover, some authors suggest that the loss of "normal" E-cadherin expression can be an early stage in the carcinogenesis of the intestinal-type gastric carcinoma [25] . We observed a relationship between the loss of E-cadherin expression and lymph node involvement. Similar results were reported by Karayiannakis et al. [24] , who showed that "abnormal" E-cadherin expression (loss of membrane expression) correlated with metastases to lymph nodes. Also Ohno et al. [26] reported that tumors with "abnormal" E-cadherin expression positively correlated with venous invasion and lymph node metastasis. However, other researchers described lack of correlation between "abnormal' E-cadherin expression and lymph node involvement [27] . No correlation was also found between E-cadherin expression and the lymphatic pathway of invasion or lymph node metastasis [28] . The E-cadherin-catenin complex plays a fundamental role in the development and maintenance of adhesion between epithelial cells. Changes in any of its components may lead to loss of cell adhesion and thus contribute to cancer formation [26] . Mutation in E-cadherin causes "abnormal" nuclear β-catenin location. We observed positive β-catenin expression most frequently in tumors surpassing the serosa or penetrating all over the gastric wall as compared to carcinomas invading the mucous and submucous membrane and the muscular layer. Similar results were reported by Utsunomjya et al. [31] , who described β-catenin expression as normal or abnormal. Abnormal expression significantly correlated with diffuse-type adenocarcinoma and invasion depth. However, according to other researchers no correlation can be found between E-cadherin or β-catenin expression and the invasion depth [27] . What is more, neither nuclear nor cytoplasmatic expression was found in the deep gastric wall referred to as the invasion front [32] . This is in agreement with the finding reported by Miyazawa et al. [33] that the nuclear β-catenin expression becomes reduced in correlation with depth of invasion. Statistical analysis showed a significant relationship between β-catenin expression and lymph node metastasis. This has been confirmed in literature [27] . The expression of β-catenin was found to be closely correlated with lymph node involvement and was substantially higher when lymph node metastasis were present [34] . On the other hand, "abnormal" β-catenin expression showed no correlation with lymph node involvement [31] . We observed positive reaction for β-catenin mainly in carcinomas located in 1/3 of the lower or central part of the stomach or occupying the whole organ. However, we found no correlation between β-catenin expression in the main mass of tumor and its histological differentiation according to Lauren criteria and patients' gender, which has been confirmed by other authors [35, 36] . On the other hand, Ohno et al. [26] showed a statistically significant correlation between β-catenin expression and degree of tumor histological differentiation. A reduction in membranous β-catenin expression was associated with age, gender, tumor size or lymph node involvement, but not with histological type, tumor progression or prognosis in gastric carcinoma [36] . However, the reduction was related to low tumor differentiation grade [35] . The "abnormal" β-catenin expression closely correlated with diffusetype gastric adenocarcinoma [31] . We observed a strong, statistically significant correlation of γ-catenin expression in the main mass of tumor with Lauren's classification and histological differentiation grade. Positive staining for this protein was more common in the intestinal type at moderate grade of differentiation (G2). The other clinicopathological parameters did not correlate with γ-catenin expression. Moreover, we found no relationship between any of the parameters examined and tumor α-catenin expression. This is not consistent with the findings reported by Joo et al. [37] , who observed reduced expressions of E-cadherin, α-, β-and γ-catenin much more frequently in diffuserather than intestinal-type early carcinoma according to Lauren's classification. A reduction in the expression of the E-cadherin-catenin complex correlated with low differentiation grade but not with age, gender, tumor size, location, macroscopic type, depth of invasion or lymph node involvement. This seems to indicate that dysfunction of the E-cadherin-catenin complex in the early stage of carcinogenesis plays a critical role in damaging tissue architecture and differentiation in early gastric carcinomas [37] . The E-cadherincatenin complex may have an important role in the genesis of histological differentiation and may serve as a marker of gastric carcinoma differentiation [38] . The complex plays a key part in the intercellular adhesion of epithelial cells. Abnormal expression (cytoplasmic) and function of its respective components are involved in tumor progression and metastasis. A significant relationship has been revealed between the expression of E-cadherin and β-catenin with histological type and differentiation grade of gastric carcinoma. Moreover, a correlation has been found between the expression of γ-catenin and histological type [39] . Abnormal expression of the E-cadherin-catenin complex may affect tumor growth type. Song et al. [40] showed a relationship between the complex expression and tumor growth inhibition in the stomach. The change in the complex expression from membranous to cytoplasmic seems to affect the macroscopic pattern of tumor growth, similarly to Lauren's classification, stage of advancement or size [40] . In our study, positive staining for the E-cadherin-catenin complex proteins was more frequent in the intestinal type tumors. However, Shun et al. [41] observed the expression of E-cadherin, α-and γ-catenin in diffuse type tumors according to Lauren's classification. Moreover, they found higher frequency of abnormal E-cadherin expression and lower frequency of abnormal β-catenin level in patients with lymph node involvement [41] . In our study, the survival rate in patients with advanced gastric carcinoma showed a statistically significant correlation with E-cadherin expression in the main mass of tumor. In E-cadherin positive patients, survival rate was significantly lower as compared to those without the expression, which suggests that positive staining for this protein in tumor is an unfavorable prognostic factor. We observed similar correlation between γ-catenin expression in the main mass of tumor and survival rate. These data, however, were not statistically significant. We also demonstrated that the survival time in patients with tumor α-and β-catenin expression was much longer as compared to those without. The results may indicate a prognostically beneficial role of α-and β-catenin in patients with advanced gastric carcinomas. The data, however, were not statistically significant. Ramesh et al. [35] revealed a relationship between the reduction in β-catenin expression and low differentiation grade of gastric cancers and shorter survival, but not between E-cadherin or α-catenin expression and survival. The results suggest that reduced membranous β-catenin expression may implicate unfavorable prognosis in gastric carcinoma. The expression of β-catenin, like invasion depth and lymph node involvement, was an independent prognostic factor associated with shorter survival time after surgery [31] . Longer postoperative survival was noted for carcinomas in which membranous β-catenin expression was maintained irrespective of carcinoma type, differentiation grade or advancement stage. Patients with unchanged normal membranous staining for E-cadherin and β-catenin were found to survive 3-5× longer than those with its loss [43] . Thus, the loss of membranous staining for E-cadherin and β-catenin in patients with gastric carcinoma is associated with poor prognosis [2, 38] . Liu et al. [44] observed that the 5-year-survival rate in patients with lymph node metastases and with adhesion molecule expression (cad-cat complex) was significantly lower as compared to those with metastasis and absent complex protein expression. A comparison of the expression pattern between the main mass of tumor and the affected lymph node can provide new information for patients with advanced gastric carcinoma [44] . Summing up, our findings indicate a relationship between the expression of the E-cadherin-β-catenin complex and lymph node involvement in advanced gastric carcinomas. Moreover, we observed a correlation between the expression of α-, β-catenin and such invasion factors as tumor differentiation grade or Lauren's classification. We also demonstrated that the E-cadherin expression can be an unfavorable prognostic factor for patients with gastric carcinoma.
